MedTrace Logo

Predictors of Respiratory Failure in SARS-Cov-2 Infection

NCT04316949 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 350

Last updated 2020-04-07

No results posted yet for this study

Summary

The emergence of SARS-CoV-2 is currently engaging and consuming most of resources of efficient healthcare systems in Europe, and several hospitals are currently experiencing a shortage of ICU beds for critically-ill patients with SARS-CoV-2 pneumonia.

A risk stratification based on clinical, radiological and laboratory parameters seems necessary in order to better identify those patients who may need ICU admission and/or those who may benefit from a prompt antiviral therapy

Conditions

  • SARS-CoV-2 Pneumonia

Sponsors & Collaborators

  • University of Bologna

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-03-20
Primary Completion
2020-04-30
Completion
2020-05-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04316949 on ClinicalTrials.gov